DAL
84
-3
IBM
47
-3
EXC
54
3
HPE
44
-2
NWS
75
-4
FTI
71
-7
DLTR
38
-4
VNO
46
-13
C
62
4
DHI
44
-3
GT
56
-3
HIG
66
2
PFE
14
-7
HRB
59
2
COST
57
-6
ESS
62
-3
MAS
52
-4
SBUX
37
-2
MSFT
48
-9
XOM
42
-6
DAL
84
-3
IBM
47
-3
EXC
54
3
HPE
44
-2
NWS
75
-4
FTI
71
-7
DLTR
38
-4
VNO
46
-13
C
62
4
DHI
44
-3
GT
56
-3
HIG
66
2
PFE
14
-7
HRB
59
2
COST
57
-6
ESS
62
-3
MAS
52
-4
SBUX
37
-2
MSFT
48
-9
XOM
42
-6
Financhill
Back

Pacific Biosciences of California Vs. Neurogene Industry Stock Comparison

Sell
38

PACB
Pacific Biosciences of California

Last Price:
1.60
Seasonality Move:
21.6%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
38
Pacific Biosciences of California (PACB) is a Sell

Is Pacific Biosciences of California a Buy, Sell or Hold?

  • The current Pacific Biosciences of California [PACB] share price is $1.60. The Score for PACB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • PACB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PACB Stock Price Chart

What is Pacific Biosciences of California's stock price today?

  • The Pacific Biosciences of California share price today is $1.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

PACB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 37.01 Sell
Chaikin Money Flow: -17716950 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.8 - 2.38) Sell
Bollinger Bands (100): (1.43 - 2.07) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

PACB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.19 Sell
20-day SMA: 2.11 Sell
50-day SMA: 1.91 Sell
200-day SMA: 2.5 Sell
8-day EMA: 2.04 Sell
20-day EMA: 2.08 Sell
50-day EMA: 1.95 Sell
200-day EMA: 3.05 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

Pacific Biosciences of California Earnings Growth & PACB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $0.17 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Pacific Biosciences of California Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):